QUADRANT CAPITAL GROUP LLC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$114
-96.9%
11
-96.0%
0.00%
Q2 2023$3,632
+17.3%
2770.0%0.00%
Q1 2023$3,097
+3230.1%
277
+2418.2%
0.00%
Q4 2022$93
-90.7%
11
-47.6%
0.00%
Q1 2022$1,000
-90.0%
21
-93.1%
0.00%
-100.0%
Q4 2021$10,000306
+2450.0%
0.00%
Q3 2021$0120.00%
Other shareholders
PULMONX CORP shareholders Q2 2022
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 994,971$43,898,0008.08%
ABG-WTT Global Life Science Capital Partners GP Ltd 93,831$4,140,0008.00%
Miura Global Management 570,000$25,148,0004.59%
Iron Triangle Partners LP 550,000$24,266,0002.50%
Beck Bode, LLC 116,442$5,137,0001.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,800,887$79,455,0001.41%
Affinity Asset Advisors, LLC 60,000$2,647,0000.95%
PURA VIDA INVESTMENTS, LLC 595,231$26,262,0000.82%
RTW INVESTMENTS, LP 1,129,600$49,838,0000.75%
ABG Innovation Capital Partners III GP Ltd 4,521$199,0000.67%
View complete list of PULMONX CORP shareholders